Clarus Therapeutics Holdings Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing to assess a product’s safety profile.
Clarus Therapeutics Holdings, Inc., formerly Blue Water Acquisition Corp., is a specialty pharmaceutical company. The Company is focused on the commercialization of JATENZO, an oral T-replacement, or T-replacement therapy (TRT). The Company’s lead product, JATENZO, an androgen indicated for T-replacement therapy to treat adult men with hypogonadism due to certain medical conditions.
Company Website: https://clarustherapeutics.com